FX005

· Pacira Pharmaceuticals, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FX005, covering 2024-01-24 to 2024-01-24. Get the full timeline:

Most recent: Clinical Trial Update: Study of FX005 for the Treatment of Pain in Patients With Osteoarthritis of the Knee [Phase 1, Phase 2]